Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene

• Miljana Tanic,

  Affiliation Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Kira Yanowsky,

  Affiliations Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯
• Cristina Rodriguez-Antona,

  Affiliation Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Raquel Andrés,

  Affiliation Medical Oncology Service, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain

  ⨯
• Iván Márquez-Rodas,

  Affiliation Medical Oncology Service, Hospital Gregorio Marañón, Madrid, Spain

  ⨯
• Ana Osorio,

  Affiliations Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯
• Javier Benitez,

  Affiliations Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯
• Beatriz Martinez-Delgado

  * E-mail: bmartinez@cnio.es

  Affiliations Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain

  ⨯